Could testosterone be the new methadone? New ways for approaching anabolic-androgenic steroid dependence (Editorial)
Files
File version
Accepted Manuscript (AM)
Author(s)
Havnes, Ingrid
Kill, Emma
van de Ven, Katinka
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
Abstract
Testosterone serves both therapeutic and performance-enhancing purposes. Therapeutically, it addresses symptoms of testosterone deficiency, benefiting health outcomes, especially in aging men (Bhasin et al., 2024; Traish, 2018). However, non-medical use for performance enhancement, including muscle growth and recovery, raises complexities (Dunn et al., 2021). This dual nature of testosterone is exemplified in its therapeutic benefits for health conditions like HIV-associated weight loss and osteoporosis and its non-medical use, regulated due to fairness concerns in sports. The intersection of therapeutic use, performance enhancement, and anti-doping policies is believed to add layers of complexity to testosterone replacement – but does it really?
Journal Title
Performance Enhancement and Health
Conference Title
Book Title
Edition
Volume
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2024. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
Item Access Status
Note
This publication has been entered in Griffith Research Online as an advanced online version.
Access the data
Related item(s)
Subject
Health policy
General practice
Sociology and social studies of science and technology
Public health
Sports science and exercise
Persistent link to this record
Citation
Piatkowski, T; Havnes, I; Kill, E; van de Ven, K, Could testosterone be the new methadone? New ways for approaching anabolic-androgenic steroid dependence, Performance Enhancement and Health, 2024, pp. 100275